Literature DB >> 10487955

Malignant triton tumor of the head and neck: A case report and review of the literature.

L Victoria1, T M McCulloch, E J Callaghan, N M Bauman.   

Abstract

BACKGROUND: Malignant triton tumor (MTT) is a relatively rare, aggressive tumor comprised of both malignant schwannoma cells and malignant rhabdomyoblasts. Because MTT frequently arises in the head and neck, the otolaryngologist must be aware of the nature of the tumor and its response to various treatment modalities.
METHOD: This article reviews the treatment and outcome of all reported cases of MTT arising in the head and neck.
CONCLUSIONS: Although statistical analysis is limited by the short duration of follow-up of many patients, complete tumor resection appears to carry an improved chance of survival. Adjuvant radiation and chemotherapy may also improve survival, although a benefit of these therapies was not well demonstrated in this small series. Copyright 1999 John Wiley & Sons, Inc. Head Neck 21:663-670, 1999.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10487955     DOI: 10.1002/(sici)1097-0347(199910)21:7<663::aid-hed12>3.0.co;2-4

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  13 in total

Review 1.  Biphenotypic sinonasal sarcoma: demographics, clinicopathological characteristics, molecular features, and prognosis of a recently described entity.

Authors:  Simon Andreasen; Justin A Bishop; Henrik Hellquist; Jennifer Hunt; Katalin Kiss; Alessandra Rinaldo; Alena Skálová; Stefan M Willems; Michelle Williams; Alfio Ferlito
Journal:  Virchows Arch       Date:  2018-08-14       Impact factor: 4.064

2.  Growth inhibitory and anti-tumour activities of OSU-03012, a novel PDK-1 inhibitor, on vestibular schwannoma and malignant schwannoma cells.

Authors:  Tina X Lee; Mark D Packer; Jie Huang; Elena M Akhmametyeva; Samuel K Kulp; Ching-Shih Chen; Marco Giovannini; Abraham Jacob; D Bradley Welling; Long-Sheng Chang
Journal:  Eur J Cancer       Date:  2009-04-07       Impact factor: 9.162

Review 3.  Rhabdomyoblastic Differentiation in Head and Neck Malignancies Other Than Rhabdomyosarcoma.

Authors:  Justin A Bishop; Lester D R Thompson; Antonio Cardesa; Leon Barnes; James S Lewis; Asterios Triantafyllou; Henrik Hellquist; Goran Stenman; Jennifer L Hunt; Michelle D Williams; Pieter J Slootweg; Kenneth O Devaney; Douglas R Gnepp; Bruce M Wenig; Alessandra Rinaldo; Alfio Ferlito
Journal:  Head Neck Pathol       Date:  2015-03-11

4.  Malignant triton tumor: a rare case.

Authors:  Prasad K Shetty; Sameer V Baliga; Kopparthi Balaiah
Journal:  Indian J Surg       Date:  2012-07-28       Impact factor: 0.656

5.  Malignant triton tumor of the chest wall invading the lung. A case report and literature review.

Authors:  E Kamperis; N Barbetakis; C Asteriou; A Kleontas; V Christoforidou
Journal:  Hippokratia       Date:  2013-07       Impact factor: 0.471

Review 6.  Malignant triton tumor of the retroperitoneum: a case report and review of the literature.

Authors:  Zhiwei Li; Jie Xiang; Sheng Yan; Feng Gao; Shusen Zheng
Journal:  World J Surg Oncol       Date:  2012-05-30       Impact factor: 2.754

Review 7.  A-Z of malignant peripheral nerve sheath tumors.

Authors:  S C Kamran; A B Shinagare; S A Howard; J L Hornick; N H Ramaiya
Journal:  Cancer Imaging       Date:  2012-10-26       Impact factor: 3.909

Review 8.  Primary epididymis malignant triton tumor: case report and review of the literature.

Authors:  Lijian Gao; Hualin Song; Kun Mu; Jiaxin Wang; Baoyin Guo; Benkang Shi; Gang Li
Journal:  Eur J Med Res       Date:  2015-09-21       Impact factor: 2.175

9.  Malignant Triton Tumor of the Sciatic Nerve as a Secondary Malignancy after Extended Field Radiotherapy and Chemotherapy of Hodgkin's Disease.

Authors:  Mirko Nitsche; Michael Reible; Karl-Heinz Pflüger; Markus Bergmann; Robert Michael Hermann
Journal:  Case Rep Oncol       Date:  2014-03-28

10.  Malignant triton tumor of the anterior mediastinum: A case report.

Authors:  Wei Ren; Xinyun Xu; Jing Yan; Xiaoping Qian; Baorui Liu
Journal:  Oncol Lett       Date:  2014-01-09       Impact factor: 2.967

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.